Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar
Celltrion’s Herzuma®(trastuzumab biosimilar) receives positive opinion from EMA’s CHMP for early breast cancer, metastatic breast cancer, and metastatic gastric cancer INCHEON, South Korea–(BUSINESS WIRE)– Celltrion,...